articles This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Molecule Spotlight: Risdiplam, the First Approved Small Molecule Splicing Modulator for Spinal Muscular Atrophy Spinal Muscular Atrophy (SMA)—the leading genetic cause of childhood mortality—is a disease in which the gene SMN1 is deleted or… Article 3 months ago ● 6 mins read Case StudiesPremium Molecules of the Month – July 2022 An oral, brain penetrant EGFR mutant inhibitor with exquisite selectivity, a drug that was originally developed from a brain cholesterol… Article 3 months ago ● 1 min read Molecules of the Month First Disclosures from ACS Chicago 2022 We're here at ACS Chicago 2022, covering sections of particular interest to drug discovery scientists. Among the highlights are the… Article 4 months ago ● 4 mins read Highlights Small Molecule and Biotechnology-Based Therapeutics for Neurology-Focused Companies: 2021’s IPOs Part V This article is Part 5 of a review series covering all the initial public offerings for the biotech and pharmaceutical… Article 4 months ago ● 7 mins read MinireviewPremium Agile Drug Hunting As biotech experts, risk taking is part of our business model. Without scientific and business risk, inventions would not occur… Article 4 months ago ● 8 mins read Perspectives Lenacapavir Synthesis Highlights In this guest article, Dr. Luíza Cruz breaks down the synthesis of Gilead’s lenacapavir (GS-6207), Drug Hunter’s Small Molecule of… Article 4 months ago ● 5 mins read Highlights Pages: 12345678910111213141516171819Load More
